There was a gradient of involvement by LCH from focal sinus involvement to diffuse sinus involvement and from focal paracortical involvement to diffuse paracortical involvement.
The answers were measured on a scale from 1 (No involvement) to 5 (Regular involvement).
Briefly, this consisted of slit lamp and indirect ophthalmoscopic features of the cornea, anterior chamber, iris, and vitreous in a scale of 0 (no involvement) to 4 (gross involvement) and additional allowance given for any opaque ocular tissues not allowing further examination.
When we compared the patients with LN 12/13 involvement to those without involvement, there was no significant difference in OS (21.0 months vs. 25.0 months, respectively; P = 0.140).
Generally, the working relationship between the TTs and government partners is good at the planning and programming levels, but is variable at the implementation level, ranging from strong involvement to weak involvement in the TTs.
OA grade was scored from 0 (normal) to 6 (bone loss, remodeling, deformation) and OA stage from 0 (<10% involvement) to 4 (>50% involvement) for the lateral tibia, lateral femur, medial tibia, and medial femur.
Six of the seven patients who changed from involvement to no involvement of the bone marrow had a marked decrease of the CD4/CD8 ratios in bone marrow (P=0.023; Figure 2c) but not in blood (P=0.83; Figure 2d).
1 Reported 5 year OS rates for the subgroup of patients with palpable groin metastases ranged from 52%% for superficial involvement to 12%% for deep involvement.
When we compared the patients with LN 12/13 involvement to those without involvement (i.e., T4 and/or N3 disease), there was no significant difference in OS (21.0 months vs. 25.0 months, respectively; P = 0.140).
Sensitivity, specificity, and positive and negative predictive values of MRI-visible nerve involvement to findings of nerve involvement in the pain drawing and the physical examination were also calculated.
